Rakesh Jhunjhunwala and Associates's portfolio and holdings
Visit FAQs
Rakesh Jhunjhunwala (born 5 July 1960) is an Indian Investor and trader and manages the asset firm Rare Enterprises. A qualified Chartered Accountant, he invests in both his own name and his wife's, Rekha Jhunjhunwala. Jhunjhunwala has been described as India's Warren Buffett, and his investments are closely tracked by the media. He tends to favor stocks in the finance, tech, retail and pharma sectors.
As per the latest corporate shareholdings filed, Rakesh Jhunjhunwala and Associates publicly holds 26 stocks with a net worth of over Rs. 63,314.8 Cr.
These are shares held by Rakesh Jhunjhunwala and Associates as per the shareholding data filed with the exchanges. The latest quarter tends to have missing data since not all companies may have reported their shareholding data till now.
Share
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
LIO
| Expand | Stock | Holding Value | Qty Held | Sep 2025 Change % | Sep 2025 Holding % | Jun 2025 % | Mar 2025 % | Dec 2024 % | Sep 2024 % | Jun 2024 % | Mar 2024 % | Dec 2023 % | Sep 2023 % | History | DetailsRow |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aptech | 249.1 Cr | 24,019,236 | 0.0 | 41.4% | 41.4% | 41.4% | 41.4% | 41.4% | 43.7% | 43.7% | 43.7% | 43.7% | |||
| Sundrop Brands | 145.4 Cr | 1,861,759 | 0.0 | 4.9% | 4.9% | 4.9% | 7.0% | 7.0% | 7.3% | 7.5% | 8.1% | 8.1% | |||
| Canara Bank | 1,990.9 Cr | 142,443,000 | 0.1 | 1.6% | 1.5% | 1.5% | 1.4% | 1.4% | 1.5% | 1.5% | 2.1% | 2.1% | |||
| Crisil | 1,793.1 Cr | 3,799,000 | 0.0 | 5.2% | 5.2% | 5.2% | 5.2% | 5.2% | 5.4% | 5.4% | 5.5% | 5.5% | |||
| Valor Estate | 357.6 Cr | 25,000,000 | 0.0 | 4.6% | 4.6% | 4.7% | 4.7% | 4.7% | 4.7% | 4.7% | 3.0% | 2.0% | |||
| Escorts Kubota | 621.1 Cr | 1,708,388 | 0.0 | 1.5% | 1.5% | 1.5% | 1.5% | 1.5% | 1.6% | 1.6% | 1.6% | 1.6% | |||
| Federal Bank | 1,393.1 Cr | 59,030,060 | 0.9 | 2.4% | 1.5% | 1.5% | 1.4% | 1.4% | 2.5% | 2.6% | 3.0% | 3.1% | |||
| Fortis Healthcare | 3,030.3 Cr | 30,739,000 | 0.0 | 4.1% | 4.1% | 4.1% | 4.1% | 4.1% | 4.2% | 4.1% | 4.7% | 4.7% | |||
| Geojit Fin Serv | 141.7 Cr | 20,099,400 | 0.0 | 7.2% | 7.2% | 7.2% | 7.2% | 7.0% | 7.2% | 7.3% | 8.2% | 8.2% | |||
| Indian Hotels Company | 2,017.9 Cr | 28,810,965 | 0.0 | 2.0% | 2.0% | 2.0% | 2.0% | 2.0% | 2.1% | 2.1% | 2.1% | 2.1% | |||
| Jubilant Pharmova | 1,152.3 Cr | 10,244,000 | 0.0 | 6.4% | 6.4% | 6.4% | 6.4% | 6.4% | 6.6% | 6.6% | 6.7% | 6.7% | |||
| Karur Vysya Bank | 986.5 Cr | 40,185,019 | 0.0 | 4.2% | 4.2% | 4.2% | 4.2% | 4.2% | 4.3% | 4.3% | 4.6% | 4.6% | |||
| NCC | 1,461.7 Cr | 78,333,266 | 0.0 | 12.5% | 12.5% | 12.5% | 12.5% | 12.5% | 12.5% | 12.5% | 13.1% | 13.1% | |||
| Sun Pharma Advanced | - | - | - | - | - | - | - | 1.9% | 1.9% | 1.9% | 1.9% | 1.9% | |||
| Tata Communications | 829.1 Cr | 4,500,687 | 0.0 | 1.6% | 1.6% | 1.6% | 1.6% | 1.6% | 1.6% | 1.6% | 1.8% | 1.8% | |||
| Tata Motors Passenger Vehicles | 2,015.7 Cr | 49,770,260 | 0.0 | 1.4% | 1.3% | 1.3% | 1.3% | 1.3% | 1.3% | 1.3% | 1.6% | 1.6% | |||
| Titan Company | 17,909.6 Cr | 47,293,470 | 0.2 | 5.3% | 5.2% | 5.2% | 5.1% | 5.1% | 5.3% | 5.4% | 5.4% | 5.4% | |||
| Va Tech Wabag | 700.9 Cr | 5,000,000 | -0.0 | 8.0% | 8.0% | 8.0% | 8.0% | 8.0% | 8.0% | 8.0% | 8.0% | 8.0% | |||
| Wockhardt | 379.3 Cr | 2,837,005 | 0.0 | 1.8% | 1.8% | 1.8% | 1.8% | 1.9% | 1.9% | 1.9% | 2.0% | 2.0% | |||
| Singer | 34.8 Cr | 4,250,000 | 0.0 | 6.9% | 6.9% | 6.9% | 6.9% | 7.0% | 7.0% | 7.0% | 7.0% | 7.0% | |||
| Raghav Productivity Enhancers | 217.8 Cr | 2,205,704 | 0.0 | 4.8% | 4.8% | 4.8% | 4.8% | 4.8% | 5.0% | 5.1% | 5.1% | 5.1% | |||
| Nazara Technologies | - | - | - | - | - | 7.1% | 7.2% | 8.1% | 8.4% | 8.5% | 9.0% | 10.0% | |||
| Jubilant Ingrevia | 310.2 Cr | 4,735,500 | 0.0 | 3.0% | 3.0% | 3.0% | 3.0% | 3.0% | 3.1% | 3.1% | 3.1% | 3.1% | |||
| Star Health | 4,925.4 Cr | 100,753,935 | 0.0 | 17.1% | 17.1% | 17.1% | 17.1% | 17.2% | 17.2% | 17.2% | 17.2% | 17.3% | |||
| Metro Brands | 2,895.3 Cr | 26,102,394 | 0.0 | 9.6% | 9.6% | 9.6% | 9.6% | 9.6% | 9.6% | 9.6% | 9.6% | 9.6% | |||
| Concord Biotech | 3,659.7 Cr | 25,199,240 | 0.0 | 24.1% | 24.1% | 24.1% | 24.1% | 24.1% | 24.1% | 24.1% | 24.1% | 24.1% | |||
| Baazar Style Retail | 81.3 Cr | 2,532,500 | 0.0 | 3.4% | 3.4% | 3.4% | 3.7% | 3.7% | - | - | - | - | |||
| Inventurus Knowledge | 14,015.1 Cr | 84,668,326 | 0.0 | 49.3% | 49.3% | 49.3% | 49.3% | - | - | - | - | - |